Dani Brunner

Dani Brunner

Company: PsychoGenics

Job title: Chief Innovation Officer, Chief Technology Officer


Use of Phenotypic Screening in Mice for CNS Drug Discovery 10:20 am

SmartCube is a non-biased, automated screening platform that uses AI to predict the therapeutic effects of unknown compounds based on mouse behavior SmartCube has been central to the discovery of several drugs being evaluated in the clinic for CNS disorders, including Ulotaront (in Phase 3) for Schizophrenia SmartCube reduces the cost and timelines from identification…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.